Trials / Conditions / EGFR Exon 20 Mutation
EGFR Exon 20 Mutation
3 registered clinical trials studyying EGFR Exon 20 Mutation.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations NCT05241873 | Blueprint Medicines Corporation | Phase 1 |
| Active Not Recruiting | A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer NCT04036682 | Cullinan Therapeutics Inc. | Phase 1 / Phase 2 |
| Terminated | Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC NCT03066206 | M.D. Anderson Cancer Center | Phase 2 |